Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Researchers Use CRISPR to Remove HIV From Mice

South Africa Time — Thursday, July 04, 2019

An interdisciplinary team of scientists is claiming to have eliminated the HIV virus from the genomes of mice by combining the CRISPR-Cas9 ...

View article...

LEGACY - for researchers

Top stories of the last 30 days

Nigeria : New HIV Drug May Exclude Vulnerable Populations

South Africa Time — Tuesday, June 24, 2025

The recent approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, has sparked global debate as health experts warn that its ... View article...

HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study

South Africa Time — Thursday, June 19, 2025

The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...

HIV Prevention Has a Fantastic New Treatment

South Africa Time — Thursday, June 26, 2025

A new HIV prevention vaccine, Yezturgo Lenacapavir, is not a cure but taken twice a year, the treatment provides 99.9% protection. View article...

Weight Regain After GLP-1 Discontinuation is Less Rapid in Real World: Hamlet Gasoyan, PhD

South Africa Time — Tuesday, June 24, 2025

The prevention of HIV could monumentally shift followong the FDA approval of lenacapavir on June 19, as the twice-yearly long-acting injectable form ... View article...

Kenya's war on HIV, TB and malaria faces setback as funding drops sharply

South Africa Time — Tuesday, June 17, 2025

A nearly 40 per cent cut in government funding for Global Fund-backed health programmes is threatening to undermine Kenya's fight against HIV , TB, and ... View article...

Beetle-powered TB test aids diagnosis in HIV patients

South Africa Time — Wednesday, July 02, 2025

A credit card-sized tuberculosis test that works without electricity has shown 87 per cent accuracy in detecting TB among people living with HIV . View article...

Knowledge, Attitudes, and Practices of Nurses Regarding Needle Stick Injuries, HIV, and ...

South Africa Time — Wednesday, July 02, 2025

Introduction. Needlestick injuries (NSIs) pose serious health risks to healthcare workers, especially nurses, due to the potential transmission of HIV ... View article...

Truth about Motsoaledi's big HIV treatment jump

South Africa Time — Tuesday, June 17, 2025

More than half a million people previously diagnosed with HIV have started on HIV treatment since the end of February, the health minister says. View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2025 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

Abacavir-Based ART Regimens Linked to Higher MACE Risk in Patients With HIV

South Africa Time — Monday, July 07, 2025

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens. View article...

Which Hepatitis B Vaccine Provides the Longest-Lasting Protection in People with HIV?

South Africa Time — Wednesday, July 09, 2025

A total of 561 people with HIV who had previously not responded to hepatitis B vaccination were randomized to receive two or three doses of HepB-CpG ... View article...

UN says if US funding for HIV programs is not replaced, millions more will die by 2029

South Africa Time — Thursday, July 10, 2025

UNAIDS called the program a ''lifeline'' for countries with high HIV rates, and said that it supported testing for 84.1 million people, treatment for ... View article...

Mpox can leave lasting brain damage – Swiss study

South Africa Time — Wednesday, July 09, 2025

The results were published in Nature Communications. Study details. Monkeypox virus spreads from cell-to-cell and leads to neuronal death in human ... View article...

Could This Shot Prevent HIV?

South Africa Time — Tuesday, July 08, 2025

One trial showed that people without HIV infection could take antiretroviral medications to prevent getting infected. The second trial showed that ... View article...

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2024

South Africa Time — Thursday, July 10, 2025

In 2025, the donor government funding landscape fundamentally changed. Under the new administration, the United States, the largest donor to HIV ... View article...

FDA Accepts New Drug Application for Merck's HIV Treatment, Doravirine/Islatravir

South Africa Time — Thursday, July 10, 2025

This investigational two-drug regimen for treatment of adults with virologically suppressed HIV was given a Prescription Drug User Fee Act (PDUFA) ... View article...

Merck to present new data highlighting research advancements across its HIV prevention ...

South Africa Time — Wednesday, July 09, 2025

Pifeltro is indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in adult patients with no prior ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews